Alimera Sciences Capitalización de mercado
¿Qué es el Capitalización de mercado de Alimera Sciences?
El Capitalización de mercado de Alimera Sciences Inc. es $16.83M
¿Cuál es la definición de Capitalización de mercado ?
La capitalización de mercado es el valor de mercado en un momento en el tiempo de las acciones en circulación de una empresa que cotiza en bolsa, que es igual al precio de la acción en ese punto de tiempo por el número de acciones en circulación .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Capitalización de mercado de compañías en Sector Health Care en NASDAQ en comparadas con Alimera Sciences
¿Qué hace Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Empresas con capitalización de mercado similar a Alimera Sciences
- O2i SA tiene Capitalización de mercado de $16.79M
- TNT Mines tiene Capitalización de mercado de $16.79M
- Miliboo SA tiene Capitalización de mercado de $16.79M
- e plc tiene Capitalización de mercado de $16.80M
- K2 F&B tiene Capitalización de mercado de $16.82M
- TDH Inc tiene Capitalización de mercado de $16.83M
- Alimera Sciences tiene Capitalización de mercado de $16.83M
- Travel Technology Interactive tiene Capitalización de mercado de $16.86M
- Okapi Resources tiene Capitalización de mercado de $16.86M
- Pantaflix AG tiene Capitalización de mercado de $16.87M
- Applied Genetic Technologies Corp tiene Capitalización de mercado de $16.87M
- Evgen Pharma plc tiene Capitalización de mercado de $16.87M
- UPERGY Societe Anonyme tiene Capitalización de mercado de $16.88M